News
Despite major product launches from diabetes rivals last year, Abbott’s diabetes unit brought in $1.8bn total Q1 sales to ...
Health Canada has granted approval for NanoSpeed Diagnostics’ Test4D Serum, designed to identify Vitamin D levels in blood ...
The coronary stent market in the Asia-Pacific (APAC) region is witnessing sustained growth, driven by rising coronary artery ...
The US Food and Drug Administration (FDA) has granted marketing authorisation for ActiveProtective Technologies’ (APT) Tango Belt.
The University of Birmingham has secured £230,00 ($303,000) in funding from Cancer Research Horizons towards the development ...
Researchers from Weill Cornell Medicine (WCM) and New York Genome Center (NYGC), US, have identified an “accurate” and ...
Edwards’ device, dubbed Sapien M3, is the first approved system to use a transfemoral approach to treating mitral ...
Dutch diagnostics company Inbiome has secured the EU's In Vitro Diagnostic Regulation (IVDR) certification for its rapid ...
The FDA has granted 510(k) clearance to Turbett Surgical's improved line of Instrument Pods, notably the TS1500, TS1200, and ...
NEC Laboratories Europe and Data-Driven.AI are collaborating to advance medical diagnoses with the use of artificial intelligence (AI) and machine learning (ML).
Nexalin has received patent approval from the USPTO for its DIFS method for treating substance use disorders (SUD).
Retractable Technologies is laying off around 7% of its workforce to free up resources amid market uncertainty prompted by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results